Patient-Derived Glioma Models: From Patients to Dish to Animals
Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults associated with a poor survival. Current standard of care consists of surgical resection followed by radiation and chemotherapy. GBMs are highly heterogeneous, having a complex interaction among different cells within...
Main Authors: | Cintia Carla da Hora, Markus W. Schweiger, Thomas Wurdinger, Bakhos A. Tannous |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/10/1177 |
Similar Items
-
Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
by: Ergang Wang, et al.
Published: (2022-12-01) -
The functional and clinical roles of liquid biopsy in patient-derived models
by: Ziqing Zhu, et al.
Published: (2023-04-01) -
Patient-Derived Organoids of Cholangiocarcinoma
by: Christopher Fabian Maier, et al.
Published: (2021-08-01) -
The generation of glioma organoids and the comparison of two culture methods
by: Yang Zhang, et al.
Published: (2024-02-01) -
Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma
by: XiaoChang Fang, et al.
Published: (2024-01-01)